Current stage-Stage II Posts on Medivizor
Navigation Menu

Current stage-Stage II Posts on Medivizor

Surgery followed by chemotherapy improves the outcomes of patients with rectal cancer

Posted by on Oct 13, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of surgery followed by chemotherapy without chemoradiotherapy (CRT) before surgery to treat rectal cancer. Researchers suggested that this treatment improves the outcomes of these patients.  Some background Colorectal cancer is the third most common cancer worldwide. The standard...

Read More

Is there a best duration of post-surgery chemotherapy in patients with colon cancer?

Posted by on Jul 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This study compared a 3-month with a 6-month chemotherapy treatment after colon cancer surgery. Researchers suggested that the duration of the treatment should be chosen according to the patient condition. Some background Colorectal cancer is one of the most common cancers worldwide. Stage 2 and 3 colon cancer are common and curable...

Read More

Trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer

Posted by on Jul 14, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out which treatment was better before surgery for patients with HER2-positive breast cancer, trastuzumab emtansine (Kadcycla) plus pertuzumab (Perjeta), or a standard treatment. The study found that patients treated with trastuzumab emtansine plus pertuzumab (TEP) were more likely to have cancer...

Read More

Is chemotherapy immediately after colon cancer surgery safe and feasible?

Posted by on Jun 25, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the impact of starting chemotherapy treatment immediately after colon cancer surgery. Researchers suggested that this option is safe. Some background Colorectal cancer is the third most common cancer worldwide. The standard treatment is surgery and chemotherapy. However, colon cancer surgery is associated with a...

Read More

Searching for patients with locally advanced non-small cell lung cancer to test a chemoradiotherapy regimen

Posted by on May 28, 2019 in Lung cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of standard chemoradiation vs a PET base chemoradiation combination in patients with non-small cell lung carcinoma (NSCLC). The main outcomes to be measured will be side effects and survival without cancer growing or spreading. The details A treatment option for...

Read More

Looking for participants with stage 2 to 4 rectal cancer to try a new targeted therapy treatment

Posted by on May 24, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 2 trial is examining the effectiveness and safety of durvalumab (Imfinzi) in the treatment of advanced rectal cancer that is not prone to genetic abnormalities. The main outcomes to be measured will be tumor response to the treatment and side effects. This trial is being conducted in the US. The details The standard treatment...

Read More

Chemotherapy before breast conserving surgery in breast cancer – is there an increased risk of complications?

Posted by on May 21, 2019 in Breast cancer | 0 comments

In a nutshell This study investigated the effect of neoadjuvant chemotherapy (NAC; chemotherapy before surgery) in patients undergoing oncoplastic breast-conserving surgery (OBCS).  They found that NAC did not affect the rate of complications in OBCS.  Some background Breast cancer (BC) can be treated using a number of strategies....

Read More

Long-short radiation therapy before surgery is associated with better outcomes in stage 2 and 3 rectal cancer

Posted by on Apr 21, 2019 in Colorectal cancer | 0 comments

In a nutshell This study compared the survival outcomes of patients with rectal cancer who underwent short- or long-course radiation therapy (RT). Researchers suggested that long-course RT was associated with greater tumor response and survival. Some background Colorectal cancer is the third most common cancer diagnosed in the United States. The...

Read More